Screening Clinical Trials for Breast Cancer

Clinical trials are research studies that involve people. The clinical trials on this list are for breast cancer screening. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-9 of 9
  • Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

    This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
    Location: 101 locations

  • Screening MRI Scan for the Imaging of Metastatic, Unresectable, or Recurrent Breast Cancer

    This trial studies the usefulness of a screening MRI scan of the brain in patients with breast cancer that has spread to other places in the body (metastatic), cannot be removed by surgery (unresectable), or has come back (recurrent). Screening MRIs of the brain may be helpful in assessing for brain involvement by breast cancer, if it has occurred.
    Location: 2 locations

  • Online Genetics Educational Video with or without Pre- and / or Post-Telephone Genetics Counseling in Assessing Cancer-Risk Distress in Patients with Triple Negative Breast Cancer

    This randomized clinical trial studies how well online genetics educational video with or without pre- and / or post-telephone genetics counseling works in assessing cancer-risk distress in patients with triple negative breast cancer. Online genetic education and telephone genetic counseling may help the doctors learn the stress a person feels about their risk of cancer.
    Location: 2 locations

  • Fluid Measurements and MRI in Determining Biomarkers of Lymphatic Dysfunction in Patients with Breast Cancer

    This trial uses fluid measurements of the arm and MRI to determine biomarkers of lymphatic dysfunction in patients with breast cancer. Studying the lymphatic system (the part of your body that helps to process and clear waste products) in different ways will help doctors understand more about lymphedema (excess fluid after lymph nodes are removed) and help with prevention and management of lymphedema in patients with breast cancer.
    Location: Vanderbilt University / Ingram Cancer Center, Nashville, Tennessee

  • Restriction Spectrum Imaging or Conventional and Abbreviated MRI in Screening Participants Who May Have Breast Cancer

    This trial compares restriction spectrum imaging (RSI) with conventional and abbreviated magnetic resonance imaging (MRI) in screening participants who may have breast cancer. MRI uses a strong magnet to produce detailed pictures of the inside of the body and RSI is a technique that aims to improve the pictures produced during a MRI exam. RSI may be a better way to screen for breast cancer.
    Location: Beth Israel Deaconess Medical Center, Boston, Massachusetts

  • Contrast Enhanced Spectral Mammography and Magnetic Resonance Imaging in Detecting Breast Cancer

    This trial studies how well contrast enhanced spectral mammography and magnetic resonance imaging work in detecting breast cancer. Diagnostic procedures, such as contrast enhanced spectral mammography and magnetic resonance imaging, may help find and diagnose breast cancer. Comparing results of diagnostic procedures done before biopsy may help doctors predict a patient's response to treatment and help plan the best treatment.
    Location: Beth Israel Deaconess Medical Center, Boston, Massachusetts

  • Disseminated Tumor Cells in Blood and Bone Marrow Samples from Patients Previously Treated for Breast Cancer

    This trial studies disseminated tumor cells in blood and bone marrow samples from patients previously treated for breast cancer. Studying samples of blood and bone marrow from patients with breast cancer in the laboratory may help doctors to determine whether there are any dormant tumor cells in the body. It may also help doctors to better understand what disseminated tumor cells are and how they can be best treated to improve the treatment and prevention of breast cancer in the future.
    Location: University of Pennsylvania / Abramson Cancer Center, Philadelphia, Pennsylvania

  • Quantitative Cardiac Magnetic Resonance Imaging in Finding Heart Complications in Patients with Breast Cancer Receiving Chemotherapy

    This research trial studies quantitative cardiac magnetic resonance imaging in finding heart complications in patients with breast cancer receiving chemotherapy. One of the side effects in patients receiving chemotherapy is heart complications in which the heart muscle is weakened and no longer able to pump sufficient amounts of blood throughout the body, which can lead to shortness of breath, swollen ankles and feet, lack of energy, and a reduced capacity to carry out day-to-day activities. Identifying early signs of such heart complications using cardiac magnetic resonance may allow preventative treatment options to be made available in future.
    Location: Beth Israel Deaconess Medical Center, Boston, Massachusetts

  • Circadian Thermal Sensing to Detect Breast Disease

    The purpose of this study is to determine if Cyrcadia's Circadian Biometric Recorder (CBR™), which is attached to soft biometric patches worn on the body, can improve early breast cancer detection along with mammography or as a stand alone device.
    Location: See Clinical